Product Description: Pneumocandin B0 (L-688786) is the precursor of the synthetic antifungal agent Cancidas (Caspofungin acetate) (HY-17006). Pneumocandin B0 can be isolated from fungus Glarea lozoyensis[1][2][3].
Applications: COVID-19-immunoregulation
Formula: C50H80N8O17
References: [1]Welch CJ, et al. Preparation and evaluation of novel stationary phases for improved chromatographic purification of pneumocandin B0. J Chromatogr A. 2006 Jan 6;1101(1-2):204-13./[2]Leonard WR Jr, et al. Synthesis of the antifungal beta-1,3-glucan synthase inhibitor CANCIDAS (caspofungin acetate) from pneumocandin B0. J Org Chem. 2007 Mar 30;72(7):2335-43./[3]Song P, et al. Metabolomics profiling reveals the mechanism of increased pneumocandin B0 production by comparing mutant and parent strains. J Ind Microbiol Biotechnol. 2018 Sep;45(9):767-780.
CAS Number: 135575-42-7
Molecular Weight: 1065.21
Compound Purity: 96.54
Research Area: Infection
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Drug Intermediate